UniFirst Announces Financial Results for the Third Quarter of Fiscal 2025

UniFirst Announces Financial Results for the Third Quarter of Fiscal 2025 GlobeNewswire July 02, 2025 WILMINGTON, Mass., July 02, 2025 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) (the “Company,” “UniFirst” or “we”) today reported results for its third quarter ended May 31, 2025 as compared to the corresponding period in the prior fiscal year: Q3 […]

NVTC Announces the 2025 Kilberg Scholarship Recipients

Scholarship supports Five Outstanding Young Women Pursuing STEM Careers The Northern Virginia Technology Council (NVTC), the region's premier trade association representing the technology community, proudly announces the five recipients of the 2025 NVTC Foundation Kilberg Scholarship. Now in its fifth year, the scholarship fund was established in 2021 at the Community Foundation for Northern Virginia

Hikma receives FDA approval for TYZAVAN™ (Vancomycin Injection, USP) in the US

Ready-to-infuse sepsis therapy marks new advancement in time-critical treatment Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announced the approval of a novel formulation of the first-of-its-kind, ready-to-infuse formulation of vancomycin, under the brand name TYZAVAN™(Vancomycin Injection, USP), by the US Food and Drug Administration (FDA). https://mma.prnewswire.com/media/1165956/Hikma_Primary_Coral_Logo.jpg TYZAVAN™is a glycopeptide antibacterial indicated for the

Virtusa Named a Major Contender in Everest Group’s Healthcare Data, Analytics, and AI Services PEAK Matrix® Assessment 2025

Recognized for advancing vision and capability in data-driven healthcare transformation Virtusa Corporation, a global provider of digital strategy, digital engineering, and IT services, today announced that it has been positioned as aMajor Contenderin theEverest Group Healthcare Data, Analytics, and AI Services PEAK Matrix® Assessment 2025. This recognition reflectsVirtusa's continued commitment to helping healthcare organizations unlock

CYFOX Joins Wiz Integrations Network (WIN) to Reinvent Compliance: From Cyber Defense to GRC and compliance Intelligence

CYFOX, a leader in Agentic AI for cybersecurity and compliance, is proud to announce a partnership with Wiz, theleading cloud security platform. Wiz and CYFOX customers can now benefit from the native integration between Wiz and CYFOX OmniSec, the Agentic AI-powered GRC platform. This integration streamlines compliance workflows by automatically linking cloud security posture data

IDMC Provides Positive Recommendation for Bio-Thera Solution’s BAT4406F (ADCC-Enhanced Anti-CD20 mAb) in Neuromyelitis Optica Spectrum Disorder Based on Interim Analysis of Pivotal Phase II/III Trial

Bio-Thera Solutions, Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, today announced that the Independent Data Monitoring Committee (IDMC) has recommended early study termination for the pivotal Phase II/III trial of BAT4406F in neuromyelitis optica spectrum disorder (NMOSD) based on positive interim analysis results. Following this recommendation, Bio-Thera has

Cathexis Successfully Completes the $5.8 Billion Sale of Yondr Group to DigitalBridge and La Caisse

Transaction represents a successful exit for Cathexis, which founded Yondr in 2018 Cathexis Holdings, L.P. (“Cathexis”) today announced the successful completion of the sale of Yondr Group (“Yondr”), a global developer, owner, and operator of hyperscale data centers, to DigitalBridge Group, Inc. (NYSE: DBRG) (“DigitalBridge”) and La Caisse (formerly CDPQ) for $5.8 billion. https://mma.prnewswire.com/media/2723308/Cathexis_Holdings_LP_Logo.jpg Yondr

KnowBe4 Urges Organizations to Recognize Social Engineering’s Critical Role in Ransomware Surge

Amidst rising ransomware-related attacks, KnowBe4 shares five pivotal tips to reduce human risk this Ransomware Awareness Month KnowBe4, the world-renowned cybersecurity platform that comprehensively addresses human risk management, is shining a spotlight on the critical role social engineering plays in the global surge of ransomware attacks. As part of Ransomware Awareness Month in July, KnowBe4

PRIVACY ALERT: Marlboro-Chesterfield Pathology, P.C. Under Investigation for Data Breach of Over 235,000 Patient Records

Schubert Jonckheer & Kolbe LLP is investigating a data breach impacting the sensitive personal and health information of 235,911 patients of Marlboro-Chesterfield Pathology (MCP), a North Carolina-based full-service anatomic pathology lab. On May 9, 2025, MCP publicly disclosed to theU.S. Department of Health and Human Servicesthat it had experienced a data breach involving unauthorized access

Bon Announces Breakthrough Order for $16 Million Gut-Health Products

Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solutions provider in the natural, health, and personal care industries, today announced a non-exclusive sales distribution agreement with Beijing Huahai Keyuan Technology Co., Ltd., a leading wellness company in China(“Huahai Keyuan”). The term of the agreement is 24 months with a total

Scroll to Top